Preoperative and one or more late postoperative plasma sample were available for 86 CRC patients who underwent MICR (colon 73%; rectal 27%; 40 male/46 female, mean age 64.8 ± 12.9 years) for plasma CXCL16 study. The gene discussed is CXCL16; the disease is colorectal carcinoma.